Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV.

Autor: Matveev VA; Department of Medicine, University of Toronto, Toronto ON M5S 1A8, Canada., Mihelic EZ; Department of Medicine, University of Toronto, Toronto ON M5S 1A8, Canada., Benko E; Maple Leaf Medical Clinic, Toronto ON M5G 1K2, Canada., Budylowski P; Department of Medicine, University of Toronto, Toronto ON M5S 1A8, Canada.; Institute of Medical Science, University of Toronto, Toronto ON M5S 1A8, Canada., Grocott S; Department of Medicine, University of Toronto, Toronto ON M5S 1A8, Canada.; Department of Microbiology and Immunology, McGill University, Montreal QC H3A 2B4, Canada., Lee T; CIHR Canadian HIV Trials Network (CTN), Vancouver BC V6Z 1Y6, Canada.; Centre for Health Evaluation and Outcome Sciences (CHÉOS), Vancouver BC V6Z IY6, Canada., Korosec CS; Modelling Infection and Immunity Lab, Mathematics and Statistics Department, York University, Toronto ON M3J 1P3, Canada.; Centre for Disease Modelling, Mathematics and Statistics Department, York University, Toronto ON M3J 1P3, Canada., Colwill K; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto ON M5G 1X5, Canada., Stephenson H; Department of Medicine, University of Toronto, Toronto ON M5S 1A8, Canada.; Department of Bioengineering, McGill University, Montreal QC H3A 0E9, Canada., Law R; Department of Immunology, University of Toronto, Toronto ON M5S 1A8, Canada., Ward LA; Department of Immunology, University of Toronto, Toronto ON M5S 1A8, Canada., Sheikh-Mohamed S; Department of Immunology, University of Toronto, Toronto ON M5S 1A8, Canada., Mailhot G; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto ON M5G 1X5, Canada., Delgado-Brand M; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto ON M5G 1X5, Canada., Pasculescu A; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto ON M5G 1X5, Canada., Wang JH; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto ON M5G 1X5, Canada., Qi F; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto ON M5G 1X5, Canada., Tursun T; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto ON M5G 1X5, Canada., Kardava L; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Chau S; Department of Medicine, University of Toronto, Toronto ON M5S 1A8, Canada., Samaan P; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto ON M5S 1A8, Canada., Imran A; Department of Medicine, University of Toronto, Toronto ON M5S 1A8, Canada., Copertino DC Jr; Infectious Diseases, Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA., Chao G; Department of Immunology, University of Toronto, Toronto ON M5S 1A8, Canada., Choi Y; Department of Immunology, University of Toronto, Toronto ON M5S 1A8, Canada., Reinhard RJ; Independent Public/Global Health Consultant, San Francisco, CA 94114, USA., Kaul R; Department of Immunology, University of Toronto, Toronto ON M5S 1A8, Canada., Heffernan JM; Modelling Infection and Immunity Lab, Mathematics and Statistics Department, York University, Toronto ON M3J 1P3, Canada.; Centre for Disease Modelling, Mathematics and Statistics Department, York University, Toronto ON M3J 1P3, Canada., Jones RB; Infectious Diseases, Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA., Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Singer J; CIHR Canadian HIV Trials Network (CTN), Vancouver BC V6Z 1Y6, Canada.; Centre for Health Evaluation and Outcome Sciences (CHÉOS), Vancouver BC V6Z IY6, Canada.; School of Population and Public Health, University of British Columbia, Vancouver BC V6T 1Z3, Canada., Gommerman J; Department of Immunology, University of Toronto, Toronto ON M5S 1A8, Canada., Gingras AC; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto ON M5G 1X5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto ON M5S 1A8, Canada., Kovacs C; Maple Leaf Medical Clinic, Toronto ON M5G 1K2, Canada.; Department of Internal Medicine, University of Toronto, Toronto ON M5S 1A8, Canada., Ostrowski M; Department of Medicine, University of Toronto, Toronto ON M5S 1A8, Canada.; Department of Immunology, University of Toronto, Toronto ON M5S 1A8, Canada.; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health, Toronto ON M5B 1W8, Canada.

Publikováno v: IScience [iScience] 2023 Sep 14; Vol. 26 (10), pp. 107915. Date of Electronic Publication: 2023 Sep 14 (Print Publication: 2023).

Randomized, Blinded, Placebo-Controlled Trial of De Simone Formulation Probiotic During HIV-Associated Suboptimal CD4+ T Cell Recovery.

Autor: Rousseau RK; Departments of Immunology, Medicine, and Internal Medicine, University of Toronto, Toronto, Ontario, Canada., Walmsley SL; Departments of Immunology, Medicine, and Internal Medicine, University of Toronto, Toronto, Ontario, Canada.; University Health Network, Toronto General Hospital Immunodeficiency Clinic, Toronto, Ontario, Canada.; Toronto General Hospital Research Institute, Toronto, Ontario, Canada., Lee T; CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada.; Centre for Health Evaluation and Outcomes Sciences, Vancouver, British Columbia, Canada., Rosenes R; Community Health Advocate and Consultant (Independent), Toronto, Ontario, Canada., Reinhard RJ; Public/Global Health Consultant (Independent), San Francisco, CA; and., Malazogu F; Departments of Immunology, Medicine, and Internal Medicine, University of Toronto, Toronto, Ontario, Canada., Benko E; Maple Leaf Medical Clinic, Toronto, Ontario, Canada., Huibner S; Departments of Immunology, Medicine, and Internal Medicine, University of Toronto, Toronto, Ontario, Canada., Kovacs CM; Departments of Immunology, Medicine, and Internal Medicine, University of Toronto, Toronto, Ontario, Canada.; Maple Leaf Medical Clinic, Toronto, Ontario, Canada., Singer J; CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada.; Centre for Health Evaluation and Outcomes Sciences, Vancouver, British Columbia, Canada., Kim CJ; Departments of Immunology, Medicine, and Internal Medicine, University of Toronto, Toronto, Ontario, Canada., Kaul R; Departments of Immunology, Medicine, and Internal Medicine, University of Toronto, Toronto, Ontario, Canada.; University Health Network, Toronto General Hospital Immunodeficiency Clinic, Toronto, Ontario, Canada.

Publikováno v: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2022 Feb 01; Vol. 89 (2), pp. 199-207.

Managing Expectations of an HIV Cure: What Should We Expect?

Autor: Reinhard RJ; 1 Canadian HIV Cure Enterprise , Community Liaison, Toronto, Ontario, Canada .; 2 Institut de Recherches Cliniques de Montréal , Montréal, Quebec, Canada .

Publikováno v: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2018 Jan; Vol. 34 (1), pp. 1. Date of Electronic Publication: 2017 Dec 20.